NAS
PRVA icon

Nykredit A/S’s Privia Health PRVA Stock Holding History

Nykredit A/S’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.7K Buy
+1,932
New +$44.8K ﹤0.01% 1499

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nykredit A/S's PRVA Position: Q2 2026 in Review

Nykredit A/S opened a new position in Privia Health (PRVA) in Q2 2026: 1,932 shares worth $49.7K. The stake represents ﹤0.01% of the portfolio and ranks #1499 among its holdings.

219 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Nykredit A/S held 1,932 shares of Privia Health worth $49.7K as of Q2 2026.
  • Privia Health was a new Nykredit A/S position in Q2 2026.
  • Privia Health made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1499 holding.
  • 219 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.